Incorporating Magnetic Resonance Imaging and Biomarkers in Active Surveillance Protocols - Results From the Prospective Stockholm3 Active Surveillance Trial (STHLM3AS).
Henrik OlssonTobias NordströmFredrik JäderlingLars EgevadHari T VigneswaranMagnus AnnerstedtHenrik GrönbergMartin EklundAnna Wallerstedt LantzPublished in: Journal of the National Cancer Institute (2022)
Including MRI and targeted/systematic biopsies in the follow-up for men on AS increased sensitivity of PC reclassification. Incorporation of risk prediction models including biomarkers may reduce the need for MRI use in men with low-risk PC.